California-Financed Gene Therapy Scores Historic First Commercial Approval

$5.9 million CIRM investment helps to save children from rare disease

The Lamgenhop family at Disneyland. Their children were treated in a partially CIRM-funded trial that led to the agency’s first commercial gene therapy. It is the agency’s first such success. Langenhop family photo via CIRM

SACRAMENTO, Ca. -- California’s $12 billion stem cell and gene therapy program scored a historic first today, announcing that it ha…